This protocol is judged by an institutional assessment board, an impartial group that evaluations any scientific trials involving individuals. If a study will involve a Timetable I drug, when the board approves the protocol as ethical, the scientists really have to make an application for an investigational new drug (IND) variety through the FDA.He